ProCE Banner Events

Share

APPlexus Hematology: Clinic-Ready Insights from the Top Abstracts Presented at the 2023 Annual Hematology Meeting

APPlexus Hematology is an initiative designed to address educational needs specific to APPs who care for patients with malignant or nonmalignant hematologic disorders. These webinars will navigate the profound insights from the 2023 ASH Annual Meeting (#ASH23) and will deliver innovative, real-time education to NPs and PAs worldwide. Our mission is to bridge knowledge gaps, untangle controversies, and spotlight pivotal abstracts from #ASH23 in a digestible and engaging format.

Physician Assistants/Physician Associates: 3.00 AAPA Category 1 CME credits

Nurse Practitioners: 3.00 Nursing contact hours, includes 3.00 hour of pharmacotherapy credit

Who Should Attend

This program is intended for NPs, PAs, and other healthcare professionals who care for patients with malignant or nonmalignant hematologic disorders.

Time and location

Saturday, February 10, 2024

8:00 AM - 1:20 PM Eastern Time (ET)

Virtual

Faculty
Linda Perry, MS, PA-C

Physician Assistant
Hematology
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania

Mary Steinbach, APRN

Nurse Practitioner
Blood and Marrow Transplant; Hematology; Multiple Myeloma
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah

Charise Gleason, MSN, NP-C, AOCNP,

VP and Chief APP Officer
Emory Healthcare
NP Myeloma Program Winship Cancer Institute
Adjunct Faculty Nell Hodgson Woodruff
School of Nursing
Atlanta, Georgia

Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

Catherine M. Broome, MD

Professor of Medicine
Division of Hematology/Oncology
MedStar Georgetown University Hospital
Washington, DC

Kathryn Johnson, DNP, MSc, FNP-BC,

Clinical Program Manager
Adult Leukemia & Myelofproliferative Neoplasms
Clinical Trials Program
Icahn School of Medicine at Mount Sinai
New York, New York

Agenda

Session Time (ET)         Topic
8:00 AM – 8:05 AM         Welcome
8:05 AM – 8:50 AM         Non-Malignant Hematology - Insights from ASH 2023
8:50 AM – 9:05 AM         Session Q&A
9:05 AM – 9:10 AM         Break
9:10 AM – 10:10 AM         Nonaccredited Presentation Theater: The Role of APPs in Maximizing Patient Outcomes with DARZALEX and DARZALEX FASPRO + Rd in Patients with Newly Diagnosed, Transplant Ineligible Multiple Myeloma Sponsored by Johnson & Johnson  
10:10 AM – 10:55 AM         MPNs - Insights from ASH 2023
10:55 AM – 11:10 AM         Session Q&A
11:10 AM – 11:15 AM         Break
11:15 AM – 12:15 PM         Nonaccredited Presentation Theater: A Discussion of a Real-World Patient Case of Chronic GVHD - Intervene at the First Signs of Initial Systemic Treatment Failure Sponsored by Incyte Corporation
12:15 PM – 1:00 PM         Multiple Myeloma - Insights from ASH 2023
1:00 PM – 1:15 PM         Session Q&A
1:15 PM – 1:20 PM         Closing Remarks

CME/CE Info

Goal Statement
To improve the knowledge, confidence, and skills of NPs/PAs who care for patients with malignant or nonmalignant hematologic disorders regarding the latest updates in guideline-directed evidence-based medicine, therapeutic management, and strategies to improve health equity, ultimately improving clinical outcomes for their patients. 

Target Audience
This program is intended for NPs, PAs, and other healthcare professionals who care for patients with malignant or nonmalignant hematologic disorders. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate recent clinical data to tailor and enhance treatment strategies for patients diagnosed with malignant or nonmalignant hematologic conditions.
  • Assess the implications and potential of emerging agents and therapeutic innovations in managing patients with malignant or nonmalignant hematologic disorders.
  • Evaluate the potential impact of contemporary trial outcomes on shaping future treatment paradigms for patients with malignant or nonmalignant hematologic disorders.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 3.0 contact hours, including 3.0 hours of pharmacology credit.

- Multiple Myeloma - 1.0
- MPNs - 1.0
- Non- Malignant Hematology - 1.0

Physician Associate Continuing Medical Education

Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

- Multiple Myeloma - 1.0
- MPNs - 1.0
- Non- Malignant Hematology - 1.0

IPCE Credit Designation

 

 

This activity was planned by and for the healthcare team, and learners will receive 3.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

- Multiple Myeloma - 1.0
- MPNs - 1.0
- Non- Malignant Hematology - 1.0

Disclosure of Conflicts of Interest 
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to PACE policies.

Acknowledgement

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

Supported by an educational grant from AbbVie Inc.

Contact Information

For customer support please click here.

Mailing Address:

 

Practicing Clinicians Exchange
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.